Effects of experimental conditions on solubility measurements for BCS classification in order to improve the biowaiver guidelines.

dc.contributor.authorMonteiro, Patrícia Fernanda
dc.contributor.authorBarcellos, Neila Marcia Silva
dc.contributor.authorCaldeira, Tamires Guedes
dc.contributor.authorReis, Adriana Cotta Cardoso
dc.contributor.authorRibeiro, Amanda Santos
dc.contributor.authorSouza, Jacqueline de
dc.date.accessioned2022-11-04T18:07:09Z
dc.date.available2022-11-04T18:07:09Z
dc.date.issued2021pt_BR
dc.description.abstractAmong the methods described for determining the solubility, shake-flask is suitable to evaluate the equilibrium solubility according to the BCS. Nevertheless, experimental conditions related to the shake-flask method are not well described. Evaluating the effects of experimental conditions on solubility measurements by shake-flask method is important and contributes in biowaiver decision. For this work, propranolol hydrochloride and nimesulide were used as model compound of high and low solubility, respectively. Equilibrium solubility was evaluated at 37 oC, 100 rpm during 48 hours in buffer media. Effects of the rotation speed, temperature, substance in excess and aliquot withdrawn were evaluated. Small variations of temperature caused significant differences in the solubility and then this parameter must be controlled. Excess of raw material influenced the results of the nimesulide, then, little excess is recommended. Rotation speed did not cause differences in the equilibrium solubilities, but at 150 rpm the equilibrium was reached faster. Aliquot did not present significant differences, but excessive withdrawn should be avoided. Therefore, the evaluation of equilibrium solubility using shake-flask method must be performed in physiological pH conditions, 37 ± 1 oC, substance in excess 10% above saturation, 50, 100 or 150 rpm and aliquot withdrawn not more than 10% of the media volume.pt_BR
dc.identifier.citationMONTEIRO, P. F. et al. Effects of experimental conditions on solubility measurements for BCS classification in order to improve the biowaiver guidelines. Brazilian Journal of Pharmaceutical Sciences, v. 57, 2021. Disponível em: <https://www.scielo.br/j/bjps/a/VqzsXXq6BnPb3QJ3mdn8pcS/>. Acesso em: 11 out. 2022.pt_BR
dc.identifier.doihttps://doi.org/10.1590/s2175-979020200004181083pt_BR
dc.identifier.issn2175-9790
dc.identifier.urihttp://www.repositorio.ufop.br/jspui/handle/123456789/15749
dc.language.isoen_USpt_BR
dc.rightsabertopt_BR
dc.rights.licenseThis is an open-access article distributed under the terms of the Creative Commons Attribution License. Fonte: o PDF do artigo.pt_BR
dc.subjectShake-flaskpt_BR
dc.subjectPropranolol hydrochloridept_BR
dc.subjectNimesulidept_BR
dc.titleEffects of experimental conditions on solubility measurements for BCS classification in order to improve the biowaiver guidelines.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
ARTIGO_EffecsExperimentalConditions.pdf
Tamanho:
408.31 KB
Formato:
Adobe Portable Document Format
Descrição:
Licença do Pacote
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: